Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 152

Results For "Act"

7966 News Found

Abbott study shows continuous glucose monitoring outperforms fingersticks in Type 2 diabetes
Clinical Trials | March 16, 2026

Abbott study shows continuous glucose monitoring outperforms fingersticks in Type 2 diabetes

This study demonstrates the power of real-time glucose information for people with Type 2 diabetes treated with basal insulin


Zuellig Pharma expands Cialis footprint across Asia
News | March 16, 2026

Zuellig Pharma expands Cialis footprint across Asia

The expanded ownership is expected to improve access to Cialis for millions of men in Asia affected by ED and BPH


Finerenone hits major goal in Phase III FIND-CKD trial
Clinical Trials | March 16, 2026

Finerenone hits major goal in Phase III FIND-CKD trial

There are limited treatment options available for patients living with non-diabetic CKD, and the unmet need is high for new treatments to delay kidney disease progression and reduce cardiovascular risk


China’s NMPA approves Zydus-licensed anaemia drug Desidustat
News | March 15, 2026

China’s NMPA approves Zydus-licensed anaemia drug Desidustat

Desidustat tablets are a novel oral HIF-PHI approved for treating anaemia in non-dialysis adult CKD patients


GelMEDIX partners with Catalent to advance vision-restoring cell therapies
News | March 14, 2026

GelMEDIX partners with Catalent to advance vision-restoring cell therapies

The biotechnology company will tap into Catalent’s expertise in induced pluripotent stem cells and advanced cell-therapy manufacturing


Single-use gloves misused across India, raising health risks
Healthcare | March 14, 2026

Single-use gloves misused across India, raising health risks

One task, one interaction, one pair, experts advocate


Wanbury bags key Brazil nod, eyes market expansion
News | March 14, 2026

Wanbury bags key Brazil nod, eyes market expansion

Pharmaceutical manufacturer Wanbury Limited (WL) has strengthened its position in the Brazilian market after securing regulatory approval for Sertraline Form II from Brazil’s health regulator, ANVISA


Jubilant Ingrevia acquires Remidex Pharma for Rs 16.5 crore
News | March 14, 2026

Jubilant Ingrevia acquires Remidex Pharma for Rs 16.5 crore

Remidex manufactures micronutrient premixes and nutraceuticals,


WHO Foundation and Novo Nordisk join hands to fight childhood obesity in India
News | March 14, 2026

WHO Foundation and Novo Nordisk join hands to fight childhood obesity in India

The initiative will focus on creating healthier early-life environments, promoting physical activity, identifying risks early, and strengthening preparedness within primary health care systems


BioNTech co-founders launch new mRNA venture, aiming to revolutionize next-gen therapies
News | March 14, 2026

BioNTech co-founders launch new mRNA venture, aiming to revolutionize next-gen therapies

The new entity will operate with separate resources, funding, and operations, while BioNTech will contribute related rights and mRNA technologies to support its ambitious mission